Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions

Report Code: PHM177C

Publish Date: Mar 2025

Publisher: BCC Publishing

Category: Pharmaceuticals

Download Report Overview

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for cancer therapeutics emphasizing recurrent and metastatic divisions is expected to grow from $116.1 billion in 2024 to reach $168.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2029.

Report Includes

  • 51 data tables and 83 additional tables
  • An overview of the global market for cancer therapeutics with emphasis on recurrent and metastatic divisions
  • Analyses of global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by cancer type and region
  • A look at the factors driving the market’s growth and constraints
  • Insight into the industry value chain analysis, providing a study of the intermediaries involved
  • Description of cancer development stages, including the mechanisms of metastasis and recurrences, and the current diagnostics such as medical imaging, in vitro diagnostics technologies and treatment patterns
  • Coverage of causes, risk factors, prevalence and incidence of cancer, and information on its economic burden
  • Review of pharmacological approaches covering cytotoxic/chemotherapy, hormonal therapy, targeted therapy and combinatorial therapy and non-pharmacological treatments such as surgeries and radiation
  • Identification of the fastest-growing applications and technologies, and a review of current market trends
  • Discussion of the industry’s ESG challenges and practices
  • Review of the current market status, technology issues, industry value chain, Porter’s Five Forces, competitive landscape, R&D activity and patent analysis
  • Assessment of the vendor landscape, including the market shares of leading companies, their product portfolios and financial overviews
  • Updates on recent mergers and acquisitions, facility expansions, collaborations, investments, divestments, new products and other strategic developments
  • Profiles of the leading vendors, including Merck & Co. Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., and AstraZeneca

Report Scope

Both qualitative and quantitative data on the current dynamics impacting the global cancer therapeutics market are presented in this report. It discusses the history of cancer, its different forms, its pathophysiology, its stages of development and its mechanisms of metastasis and recurrence. It also incorporates the disease burden by knowing the epidemiology of different cancers. Treatment patterns that include both non-pharmacological (e.g., radiation, surgery) and pharmacological (e.g., hormonal therapy, targeted therapy, cytotoxic/chemotherapy, combinatorial therapy) approaches are discussed to illustrate the various therapeutic options available to patients.

Analyses of the most popular products, the state of clinical trials and new product approvals are also included in the report. The demographics of the major regions—North America, Europe, Asia-Pacific and the Rest of the World—as well as their prospects for growth, are summarized. The profiles of leading companies and the strategies of international businesses involved in the cancer treatment sector are also discussed.

Estimations of the market size for therapies that treat cancer metastases and recurrence states are included in the scope. Cancer types noted in this report include:

  • Lung.
  • Breast.
  • Liver.
  • Stomach.
  • Prostate.
  • Colorectal.
  • Gastric.
  • Cervical.
  • Bladder.
  • Kidney.
  • Ovarian.
  • Lymphoma.
  • Multiple myeloma.
  • Brain tumors.
  • Thyroid.
  • Uterine.

Additional growth potential and forecast data are discussed for the cancer therapeutics market, as well as for the cancer types, regions and countries.

For market estimates, data are provided for 2023 as the base year, with forecasts for the period of 2024 through 2029.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $108.1 Billion
Market size forecast $168.0 Billion
Growth rate CAGR of 7.7% from 2024 to 2029
Units considered $ Millions
Segments covered By Cancer Type and Region
Regions covered North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
Countries covered The U.S., Canada, Mexico, Germany, United Kingdom, Italy, France, Spain, Japan, China, India and South Korea
Key Market Drivers
  • Robust approval of oncology drugs.
  • Technological advances in cancer treatments.
  • Increasing incidence of cancer disease.
  • Promising drugs in the late stage of the pipeline.
Companies studied
ABBVIE INC.AMGEN INC.
ASTRAZENECA BAYER AG
BRISTOL-MYERS SQUIBB CO.F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.JOHNSON & JOHNSON SERVICES INC.
LILLYMERCK & CO. INC.
NOVARTIS AGPFIZER INC.
REGENERON PHARMACEUTICALS INC.SANOFI
TAKEDA PHARMACEUTICAL CO. LTD.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global market for cancer therapeutics emphasizing recurrent and metastatic divisions was valued at $108.1 billion in 2023 and is projected to reach $168.0 billion by the end of 2029.
Key factors driving the growth are the increasing incidence of cancer, robust approval of oncology drugs, and technological advancements in cancer treatments.
The market scope in this report is segmented into cancer types. Based on cancer type, the report covers lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, liver cancer, cervix cancer, bladder cancer, kidney cancer, pancreas cancer, ovary cancer, and all other cancers.
Lung cancer will dominate the cancer therapeutics market with an emphasis on recurrent and metastatic divisions.
The North American market for cancer therapeutics emphasizing recurrent and metastatic divisions was valued at $48.1 billion in 2023 and is estimated to reach $75.3 billion in 2029, at a CAGR of 7.8% during the forecast period.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions211Free
Chapter- 1: Executive Summary5Free
Chapter- 2: Market Overview10Free
Chapter- 3: Market Dynamics9Free
Chapter- 4: Regulatory Landscape4Free
Chapter- 5: Emerging Trends and Pipeline Analysis16Free
Chapter- 6: Supply Chain Analysis4Free
Chapter- 7: Market Segmentation Analysis83Free
Chapter- 8: Competitive Intelligence6Free
Chapter- 9: Sustainability in Cancers Therapeutics Market Emphasis on Recurrent and Metastatic Divisions: ESG Perspective3Free
Chapter- 10: Appendix71Free
Published - Jan-2019| Analyst - BCC Publishing| Code - PHM177B

Report Highlights

The global cancer therapeutics market should grow from $128.1 billion in 2018 to $182.0 billion by 2023 at a compound annual growth rate (CAGR) of 7.3% for the period of 2018-2023.

Published - Dec-2017| Analyst - Paul Taylor| Code - PHM177A

Report Highlights

The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022.

Related Reports

Artificial Intelligence (AI) in Cancer

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO196B

The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.

Global Oncology Pharmaceuticals Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - PHM256B

The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.

Multi-Cancer Diagnostic Tests: Global Market Outlook

Published - Mar 2024 | Publisher - BCC Publishing | Code - MDS101A

This report provides an in-depth analysis of the global multi-cancer diagnostic (MCD) test market. It highlights the current and future market potential of the tests along with a detailed analysis of the drivers and challenges in the market. The report includes the company profiles of the key players with detailed information about their product portfolios and pipeline products.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Recent Reports

Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions

Published - Mar 2025 | Publisher - BCC Publishing | Code - PHM177C

The global market for cancer therapeutics emphasizing recurrent and metastatic divisions is expected to grow from $116.1 billion in 2024 to reach $168.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2029.

Epigenetics: Technologies and Global Markets

Published - Mar 2025 | Publisher - BCC Publishing | Code - PHM044D

The global market for epigenetics research tools and reagents, IVDs and therapeutics is expected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029.

High-Throughput Screening: Technologies and Global Markets

Published - Feb 2025 | Publisher - BCC Publishing | Code - PHM205B

The global market for high-throughput screening (HTS) is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.5% from 2024 through 2029.

Neurology Market: A BCC Research Overview

Published - Feb 2025 | Publisher - BCC Publishing | Code - PHM215B

The global market for neurology is estimated to increase from $67.3 billion in 2024 to reach $94.8 billion by 2029, at a compound annual growth rate (CAGR) of 7.1% from 2024 through 2029.

2023 Pharmaceuticals Research Review

Published - Dec 2024 | Publisher - Various Analysts | Code - PHM099H

This Pharmaceutical Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.

Top Trending Reports

Carbon Capture, Utilization & Storage Technologies

Published - Feb 2025 | Publisher - BCC Publishing | Code - EGY037G

The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.

Cell-Based Assays: Technologies and Global Markets

Published - Feb 2025 | Publisher - BCC Publishing | Code - BIO080F

The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Generative AI: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - IFT308A

The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.

Global Markets for Chemicals for Cosmetics & Toiletries

Published - Feb 2025 | Publisher - BCC Publishing | Code - CHM018K

The global market for chemicals in cosmetics and toiletries is expected to grow from $27.7 billion in 2024 to $35.0 billion by 2029, at a compound annual growth rate (CAGR) of 4.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from $810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions
Sample Report